Artiva Biotherapeutics (ARTV) Revenue (2023 - 2024)
Artiva Biotherapeutics' Revenue came in at $251,000 for FY2024, down 99.3% from $33.49 million in FY2023.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Revenue (2023 - 2024) Analysis & Trends
- Per Business Quant, earlier years put Revenue at $33.49 million in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.45 Bn | 1,141.04 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 637.59 Bn | 556.11 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 504.05 Bn | 477.16 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 377.18 Bn | 331.56 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 241.83 Bn | 197.23 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 172.51 Bn | 119.15 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Artiva Biotherapeutics | 250.87 Mn | -98.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 251,000.00 |
| Dec 31, 2023 | 2.35 Mn |
| Sep 30, 2023 | 26.66 Mn |
| Jun 30, 2023 | 3.50 Mn |
API Access
Artiva Biotherapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();